The graphite market was dominated by oversupply, trade disputes and China’s continued grip in 2025. Prices hit multi-year lows as…
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small…